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Resistance to minocycline has emerged in multidrug-resistant Acinetobacter baumannii isolates from Buenos Aires hospitals.
Few reports about the description and dispersion of tet genes in this species have been published. We observed the presence of
tet(B) in all minocycline-resistant isolates. This gene was found to be associated with the ISCR2mobile element, which may, in
part, explain its dispersion.
Recently, misconceptions regarding Acinetobacter baumanniihave been advanced, exposing the importance of this species
as a significant nosocomial pathogen (1–3). One of the important
features of A. baumannii, which may contribute to its success in
surviving in the hospital environment, is the intrinsic ability to
develop resistance to all available antibiotics to treatA. baumannii
infections (1–3).
A review of the existing literature indicates that little is de-
scribed regarding the dispersion of tetracycline resistance deter-
minants (tet) among A. baumannii clinical isolates (4–8). The
presence of resistance genes such as tet(A) and tet(B) for tetracy-
clines, most of them tetracycline efflux pumps, has been described
(4–12). It is known that Tet(A) confers resistance to tetracycline
(TET) while Tet(B) confers resistance to TET and minocycline
(MIN). In Argentina, the emergence ofminocycline resistance has
been observed in the past few years, varying from 10 to 40% resis-
tance among different centers (13).
As there are scarce data about the resistance determinants
for tetracyclines in A. baumannii and the potential therapeutic
benefit of using tetracyclines in combination treatment with
colistin and carbapenems (14, 15), we decided to search for the
presence of tetracycline resistance genes in 47 epidemiologi-
cally unrelated A. baumannii isolates. The studied isolates were
selected from a collection of 250 A. baumannii clinical isolates.
Criteria for selection included temporal representation (1983
to 2011), different hospitals (n ! 11), and different countries
(Argentina, Uruguay, and Chile). The selected isolates pos-
sessed different antibiotic resistance profiles, with all of them
resistant to tetracycline and 12 also resistant to minocycline
(Table 1). Using molecular typing techniques, we observed the
presence of a prevalent clone among the minocycline-resistant
isolates (Table 1).
To determine the presence of tet genes, we extracted total
DNA and used it to perform PCR amplification reactions ac-
cording to the manufacturer’s instructions (Promega, Madi-
son, WI). Specific primers for tet(A), tet(B), tet(M), tet(39),
and tet(H) were used (see Table S1 in the supplemental mate-
rial). We obtained positive results for the tet(A) and tet(B)
genes, and the rest of the amplification reactions were negative
(Table 1). All PCR amplification products were sequenced on
both DNA strands using an ABI Prism 3100 BioAnalyzer and
Taq FS Terminator Chemistry (Taq FS; Perkin-Elmer), and
sequence analysis was performed with the Sequencher 4.7 soft-
ware (Gene Codes Corp.) and BLAST (version 2.0) software
(http://www.ncbi.nlm.nih.gov/BLAST/).
The tet(B) gene was found in 13 extensively drug-resistant
A. baumannii isolates of our collection, with 12 of them mino-
cycline resistant (Table 1). All positive isolates were recovered
in the last year, exposing the recent emergence of this determi-
nant (Table 1). There is scant information about tet(B) gene
distribution among A. baumannii clinical isolates. The few re-
ports which investigated the presence of this gene in A. bau-
mannii clinical isolates showed a high prevalence of tet(B)
among multidrug-resistant A. baumannii isolates (6, 12).
Lately, the description of an AbaR-type genomic island in
strains belonging to the global clone 2 revealed the presence of
a tet(B) determinant in this context (9–11).
To determine the genetic platform of tet(B) in our isolates,
inverse PCR and PCRs with primers annealing in the described
structures were performed. Sequence analysis of the positive
inverse PCR products revealed the presence of the ISCR2 ele-
ment downstream of tet(R) and a sequence derived from Tn10,
which is preceded by the "ISCR2 deletion, upstream of tet(B)
(Fig. 1). The genetic platform surrounding tet(R) resembled
the recently described genetic context found in the AbaR4-type
islands (9–11). As Tn5393, containing the strA and strB genes,
was found following the ISCR2 element in the recently de-
scribed tet(B) genetic platform (9–11), PCRs were carried out
to determine their presence. All tet(B)-positive isolates con-
tained the strA and strB genes associated with the ISCR2mobile
element.
Concerning the structure upstream of the tet(B) gene, Nigro
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and Hall (10) recently found this gene within a novel AbaR4-
type island, named Tn6167 and containing the sul2 gene and a
partial copy of CR2, which is the same genetic context identi-
fied in all tet(B)-positive isolates from our study. To determine
that tet(B) was within the AbaR-type genomic organization,
specific PCRs showing that the comM gene was intact were
done (16). This gene was recognized as a target for the insertion
of AbaR-type resistance islands in multidrug-resistant strains
enclosing different resistance determinants (10, 16–18). There-
fore, the difference concerning the tet(B) genetic platform is
that our isolates do not have the tet(B) gene linked to AbaR
islands (Fig. 1).
Plasmidic DNA from Ab13205 was extracted using the QIA-
filter midi kit (Qiagen) and used to transform Escherichia coli
Top10 competent cells. Colonies were obtained in plates con-
taining 3 #g/ml of TET and subjected to plasmid DNA extrac-
tion as described above (data not shown). To confirm tet(B)
presence, plasmidic DNA was used as the template for PCR
amplification, obtaining positive results. Moreover, the MICs
to TET and MIN of the transformed E. coli Top10 cells were
determined using the Etest strips as recommended (19). MIC
results show an increase in both MICs, supporting the plasmid
location (Table 2).
On the other hand, we observed the presence of the tet(A)
TABLE 1 Description of the isolates included in the study and PCR amplification results of tet(A) and tet(B)
Isolate Hospital/country Yr Clone Tetracycline resistance tet(A) tet(B)
Ab102 H7/Argentina 1983 II TET $ $
Ab155 H7/Argentina 1994 IV TET % $
Ab115 H7/Argentina 1994 IV TET % $
Ab1 H2/Chile 1997 III TET $ $
Ab3 H2/Chile 1997 III TET $ $
Ab6 H2/Chile 1998 III TET $ $
Ab181 H7/Argentina 2001 I TET $ $
Ab7 H3/Chile 2006 III TET $ $
Ab287 H4/Argentina 2006 XIV TET % $
Ab374 H4/Argentina 2007 IV TET $ $
Ab326 H4/Argentina 2007 XIV TET $ $
Ab375 H5/Argentina 2007 I TET $ $
Ab394 H4/Argentina 2007 I TET $ $
Ab49631 H6/Argentina 2008 III TET $ $
Abu1 H1/Uruguay 2008 IV TET $ $
Abu2 H1/Uruguay 2008 IV TET $ $
Ab66285 H6/Argentina 2009 XIV TET % $
Ab98 H8/Argentina 2009 III TET $ $
Ab04 H11/Argentina 2010 III TET $ $
Ab21 H10/Argentina 2010 III TET $ $
Ab908 H8/Argentina 2011 III TET $ $
Ab13205 H8/Argentina 2011 V TET, MIN $ %
Ab13338 H8/Argentina 2011 III TET $ $
Ab13494 H8/Argentina 2011 III TET $ $
Ab14393 H8/Argentina 2011 V TET, MIN $ %
Ab15111 H8/Argentina 2011 III TET $ $
Ab47 H8/Argentina 2011 III TET $ $
Ab15424 H8/Argentina 2011 III TET % $
Ab15975 H8/Argentina 2011 III TET $ $
Ab15799 H8/Argentina 2011 III TET % $
Ab15897 H8/Argentina 2011 III TET % $
Ab15 H8/Argentina 2011 V TET, MIN $ %
Ab20 H8/Argentina 2011 V TET, MIN $ %
Ab42 H8/Argentina 2011 III TET % $
Ab53 H8/Argentina 2011 III TET $ $
Ab103 H8/Argentina 2011 III TET $ $
Ab105 H8/Argentina 2011 V TET, MIN $ %
Ab106 H8/Argentina 2011 V TET, MIN $ %
Ab107 H8/Argentina 2011 V TET, MIN $ %
Ab112 H8/Argentina 2011 III TET $ $
Ab120 H8/Argentina 2011 III TET $ $
Ab129 H8/Argentina 2011 V TET, MIN $ %
Ab133 H8/Argentina 2011 V TET, MIN $ %
Ab741019 H9/Argentina 2011 V TET, MIN $ %
Ab761457 H9/Argentina 2011 V TET, MIN $ %
Ab767339 H9/Argentina 2011 V TET, MIN $ %
Ab795672 H9/Argentina 2011 VI TET $ %
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gene in 8 out of 47 isolates. These tet(A)-positive isolates were
recovered in different years (1994, 2006, and 2011) and differ-
ent hospitals (Table 1). This gene was reported to be associated
with Tn1721-like transposon, which was reported in a clinical
A. baumannii isolate (7). In order to determine if this genetic
structure was present in our isolates, PCRs with specific prim-
ers for the Tn1721-like transposase (tnpA) and tet(A) gene were
carried out (see Table S1 in the supplemental material). When
we tested the primer combinations tetAbTnpA=R/tetAF and
tetAbTnpAF/tetAR, negative results were obtained in all
tet(A)-positive isolates, exposing the absence of this trans-
poson in our isolates and suggesting a different genetic context
for this gene.
Our results exposed a complex genetic background associ-
ated with tetracycline resistance in our A. baumannii popula-
tion, including tet(A), tet(B), and yet-unknown elements. We
also observed the presence of the tet(B) gene associated with
the plasmid-mediated ISCR2 mobile element. Lastly, we noted
that this element can be transferred and increased the MICs to
tetracycline and minocycline in E. coli. This new genetic plat-
form of the tet(B) gene, linked to the insertion sequence ISCR2,
supports a mechanism by which spread among A. baumannii
isolates is possible.
Nucleotide sequence accession number. The sequence of the
tet(B) context has been submitted to GenBank under accession
no. JX566450.
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